Correlation Between Uxi Unicomp and Suzhou Novoprotein

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Uxi Unicomp and Suzhou Novoprotein at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Uxi Unicomp and Suzhou Novoprotein into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Uxi Unicomp Technology and Suzhou Novoprotein Scientific, you can compare the effects of market volatilities on Uxi Unicomp and Suzhou Novoprotein and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Uxi Unicomp with a short position of Suzhou Novoprotein. Check out your portfolio center. Please also check ongoing floating volatility patterns of Uxi Unicomp and Suzhou Novoprotein.

Diversification Opportunities for Uxi Unicomp and Suzhou Novoprotein

0.97
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Uxi and Suzhou is 0.97. Overlapping area represents the amount of risk that can be diversified away by holding Uxi Unicomp Technology and Suzhou Novoprotein Scientific in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Suzhou Novoprotein and Uxi Unicomp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Uxi Unicomp Technology are associated (or correlated) with Suzhou Novoprotein. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Suzhou Novoprotein has no effect on the direction of Uxi Unicomp i.e., Uxi Unicomp and Suzhou Novoprotein go up and down completely randomly.

Pair Corralation between Uxi Unicomp and Suzhou Novoprotein

Assuming the 90 days trading horizon Uxi Unicomp Technology is expected to generate 1.52 times more return on investment than Suzhou Novoprotein. However, Uxi Unicomp is 1.52 times more volatile than Suzhou Novoprotein Scientific. It trades about 0.14 of its potential returns per unit of risk. Suzhou Novoprotein Scientific is currently generating about 0.12 per unit of risk. If you would invest  3,858  in Uxi Unicomp Technology on September 2, 2024 and sell it today you would earn a total of  1,537  from holding Uxi Unicomp Technology or generate 39.84% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Uxi Unicomp Technology  vs.  Suzhou Novoprotein Scientific

 Performance 
       Timeline  
Uxi Unicomp Technology 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Uxi Unicomp Technology are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Uxi Unicomp sustained solid returns over the last few months and may actually be approaching a breakup point.
Suzhou Novoprotein 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Suzhou Novoprotein Scientific are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Suzhou Novoprotein sustained solid returns over the last few months and may actually be approaching a breakup point.

Uxi Unicomp and Suzhou Novoprotein Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Uxi Unicomp and Suzhou Novoprotein

The main advantage of trading using opposite Uxi Unicomp and Suzhou Novoprotein positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Uxi Unicomp position performs unexpectedly, Suzhou Novoprotein can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Suzhou Novoprotein will offset losses from the drop in Suzhou Novoprotein's long position.
The idea behind Uxi Unicomp Technology and Suzhou Novoprotein Scientific pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated